Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, K.
Right arrow Articles by Ogihara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, K.
Right arrow Articles by Ogihara, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 26:2219, 2003
© 2003 by the American Diabetes Association, Inc.


Letters: Observations
Letter

High Degree of Mitochondrial 3243 Mutation in Gastric Biopsy Specimen in a Patient With MELAS and Diabetes Complicated by Marked Gastrointestinal Abnormalities

Kaori Inoue, MD, Hiroshi Ikegami, MD, PHD, Tomomi Fujisawa, MD, PHD, Yumiko Kawabata, MD, PHD, Maki Shintani, MD, PHD, Koji Nijima, MD, Ono Masaya, MD, Masanori Nishino, MD, Michiko Itoi-babaya, MD, Naru Babaya, MD, PHD and Toshio Ogihara, MD, PHD

From the Department of Geriatric Medicine, Osaka University Graduate School of Medicine, Osaka, Japan

Address correspondence to Hiroshi Ikegami, Department of Geriatric Medicine, Osaka University Graduate School of Medicine 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. E-mail: ikegami{at}geriat.med.osaka-u.ac.jp.

A point mutation of mitochondrial DNA at nucleotide position 3243 has been shown to cause mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) (1). This mutation, however, is also found in maternally inherited diabetes and deafness (MIDD) (2), which accounts for ~1% of the diabetic population in Japan (3). The same point mutation of mitochondrial DNA causes a wide range of symptoms that have been suggested to be due to the difference in the degree of heteroplasmy; thus, the proportion of the mutant mitochondrial DNA is divergent among different tissues (4). Little evidence, however, is available due to difficulty in obtaining viable samples from active lesions associated with complications causing symptoms. In a diabetic patient with MELAS and severe gastrointestinal disease, including functional ileus, duodenal ulcer, and acute gastric mucosal lesions, which were resistant to treatment, we had a rare opportunity to investigate the degree of heteroplasmy of the 3243 mutation in a biopsy specimen of gastric mucosa, tissue with a major lesion that causes gastrointestinal complications, compared with peripheral white blood cells.

A 21-year-old woman had diabetes (HbA1c 7.3%), bilateral hearing loss, muscle weakness, and several stroke-like episodes with high serum lactate and pyruvate levels (lactate 7.4 mmol/l and pyruvate 261 µmol/l). Neurological findings showed bilateral sensory hearing loss, bilateral external ophthalmoplegia and droopy eyelids, muscle weakness (proximal > distal), and cerebellar ataxia. Magnetic resonance imaging scans showed cerebellar atrophy and mild cerebral atrophy. Her mother, grandmother, and mother’s brother also had hearing loss, but there was no obvious family history of diabetes. She also had functional ileus, duodenal ulcer, and acute gastric mucosal lesions, which were resistant to treatment. She was diagnosed as having MELAS with diabetes and gastrointestinal disease. DNA extracted from peripheral blood cells from the patient, her mother, and her elder sister was positive for the 3243 mutation. The proportion of the mutated allele in the proband (39%) was much higher than that in her sister (19%) and mother (10%). We also analyzed mitochondrial DNA of biopsy specimens of her gastric mucosa, which exhibited a higher proportion (57%) of the mutated allele than her peripheral white blood cells (39%), suggesting that her gastrointestinal complications were attributable to a high proportion of the mitochondrial variant in the gastrointestinal tract.

A high degree of mutated mitochondria in the gastrointestinal tract was previously reported in a case without typical clinical features of MELAS but with diabetes and gastrointestinal symptoms (5). There was 70% heteroplasmy of the mutation in his gastrointestinal tract, while that in peripheral white blood cells was 37% (5). Taking these findings together, it is likely that gastrointestinal symptoms in patients with the 3243 mutation, with either MELAS or MIDD, correlate with the degree of heteroplasmy in the gastrointestinal tract. These observations provide further evidence that the clinical diversity of symptoms related to mitochondrial 3243 mutation may be due to diversity in the proportion of the mutation in each organ.

References

  1. Kari M, Jacca SM, Seija U, Anne MR: Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS): prevalence of the mutation in adult population. Am J Hum Genet 63:447–454, 1998[Medline]
  2. van-den-Oueland JM, Lemkes HH, Trembath RC, Ross R, Velho G, Massen JA: Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNALeu (UUR) gene. Diabetes 43:746–751, 1994[Abstract]
  3. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Yazaki Y: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330:962–968, 1994[Abstract/Free Full Text]
  4. Matsuo O, Ikuya N, Yuichi G: Single muscle fiber analysis in patients with 3243 mutation in mitochondrial DNA: comparison with the phenotype and the proportion of mutant gene. J Neurol Sci 159:170–175, 1998[Medline]
  5. Kishimoto M, Hashiramoto M, Kanda F, Tanaka M: Mitochondrial mutation in diabetic patient with gastrointestinal symptoms (Letter). Lancet 345:452, 1995[Medline]

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NeurologyHome page
J. Betts, M. J. Barron, S. J. Needham, A. M. Schaefer, R. W. Taylor, and D. M. Turnbull
GASTROINTESTINAL TRACT INVOLVEMENT ASSOCIATED WITH THE 3243A>G MITOCHONDRIAL DNA MUTATION
Neurology, April 8, 2008; 70(15): 1290 - 1292.
[Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Inoue, K.
Right arrow Articles by Ogihara, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Inoue, K.
Right arrow Articles by Ogihara, T.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum